Calliditas Therapeutics (CALT) stock Forecast for 2022 – 2026

Calliditas Therapeutics (CALT) stock Forecast for 2022 – 2026

Last update: 05-28-2022, 10:42

Sector: Healthcare

The share price of Calliditas Therapeutics AB (publ) (CALT) now

What analysts predict:: $61.75

52-week high/low: $33.19 / $12.55

50/200 Day Moving Average: $17.19 / $20.59

This figure corresponds to the average price over the previous 50/200 days. For Calliditas Therapeutics stocks, the 50-day moving average is the support level today.

For Calliditas Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Calliditas Therapeutics AB (publ) stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Calliditas Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Calliditas Therapeutics share be worth in 2022 - 2026?

When should I take profit in Calliditas Therapeutics stock? When should I record a loss on Calliditas Therapeutics stock? What are analysts' forecasts for Calliditas Therapeutics stock? What is the future of Calliditas Therapeutics stock?

We forecast Calliditas Therapeutics stock performance using neural networks based on historical data on Calliditas Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Calliditas Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Calliditas Therapeutics shares. This happens once a day.




Historical and forecast chart of Calliditas Therapeutics stock

The chart below shows the historical price of Calliditas Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Calliditas Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Calliditas Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 30 18.16 17.44 18.72 7.34
May 31 17.97 17.64 18.63 5.60
Jun 01 17.20 16.71 17.85 6.79
Jun 02 16.75 16.45 17.06 3.66
Jun 03 17.30 17.13 17.76 3.69
Jun 04 17.85 17.32 18.17 4.95
Jun 05 17.70 17.05 17.96 5.35
Jun 06 17.38 16.97 17.62 3.79
Jun 07 18.23 17.83 18.63 4.50
Jun 08 17.83 17.41 18.55 6.50
Jun 09 18.14 17.78 18.52 4.13
Jun 10 18.24 17.65 18.68 5.84
Jun 11 18.86 18.23 19.10 4.76
Jun 12 19.67 18.97 20.33 7.21
Jun 13 20.28 19.84 20.80 4.85
Jun 14 20.19 19.73 20.65 4.66
Jun 15 19.92 19.21 20.70 7.72
Jun 16 19.50 18.80 19.70 4.77
Jun 17 18.89 18.13 19.37 6.82
Jun 18 18.46 17.88 18.82 5.27
Jun 19 18.90 18.71 19.64 5.00
Jun 20 18.37 17.71 19.10 7.88
Jun 21 19.14 18.80 19.48 3.67
Jun 22 19.22 18.97 19.70 3.85
Jun 23 19.37 18.83 19.64 4.32
Jun 24 18.93 18.57 19.18 3.31
Jun 25 18.68 18.34 18.96 3.36
Jun 26 18.10 17.53 18.56 5.89
Jun 27 18.13 17.47 18.42 5.45
Jun 28 17.39 16.78 17.92 6.79

Calliditas Therapeutics Daily Price Targets


Calliditas Therapeutics Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $18.16. Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 6.838%.

Pessimistic target level: 17.44

Optimistic target level: 18.72


Calliditas Therapeutics Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $17.97. Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 5.303%.

Pessimistic target level: 17.64

Optimistic target level: 18.63


Calliditas Therapeutics Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $17.20. Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 6.361%.

Pessimistic target level: 16.71

Optimistic target level: 17.85


Calliditas Therapeutics Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $16.75. Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.535%.

Pessimistic target level: 16.45

Optimistic target level: 17.06


Calliditas Therapeutics Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $17.30. Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.556%.

Pessimistic target level: 17.13

Optimistic target level: 17.76


Calliditas Therapeutics Stock Forecast 06-04-2022.

Forecast target price for 06-04-2022: $17.85. Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 4.715%.

Pessimistic target level: 17.32

Optimistic target level: 18.17


CALT (CALT) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 20.68 18.60 21.97 15.38
Jul. 21.90 20.61 23.89 13.76
Aug. 23.64 21.71 25.71 15.55
Sep. 21.98 20.14 24.36 17.31
Oct. 18.51 16.65 19.43 14.30
Nov. 21.19 18.61 23.93 22.21
Dec. 24.17 22.93 25.73 10.89

Calliditas Therapeutics forecast for this year


Calliditas Therapeutics Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $20.6776. Pessimistic: $18.60. Optimistic: $21.97


Calliditas Therapeutics Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $21.8955. Pessimistic: $20.61. Optimistic: $23.89


Calliditas Therapeutics Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $23.6428. Pessimistic: $21.71. Optimistic: $25.71


Calliditas Therapeutics Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $21.9807. Pessimistic: $20.14. Optimistic: $24.36


Calliditas Therapeutics Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $18.5144. Pessimistic: $16.65. Optimistic: $19.43


Calliditas Therapeutics Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $21.1878. Pessimistic: $18.61. Optimistic: $23.93


Calliditas Therapeutics Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $24.1668. Pessimistic: $22.93. Optimistic: $25.73




Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 25.91 24.09 27.49 12.36
Feb 27.09 24.93 30.49 18.23
Mar 30.90 28.14 33.66 16.40
Apr 31.72 29.01 35.58 18.46
May 30.04 25.93 33.29 22.11
Jun 29.92 26.74 33.56 20.33
Jul 35.38 30.34 37.60 19.31
Aug 33.23 29.82 34.49 13.55
Sep 33.55 28.89 36.80 21.48
Oct 33.67 30.35 35.98 15.65
Nov 32.20 27.67 35.75 22.59
Dec 37.83 32.80 40.63 19.28

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 31.43 28.92 33.40 13.41
Feb 33.05 29.78 37.19 19.92
Mar 30.35 28.73 33.98 15.44
Apr 30.86 29.28 32.86 10.89
May 32.57 30.83 34.05 9.45
Jun 37.76 35.90 43.14 16.80
Jul 37.55 33.77 39.05 13.52
Aug 44.61 38.42 50.29 23.60
Sep 39.19 35.39 43.13 17.95
Oct 42.09 40.17 45.85 12.38
Nov 40.09 37.20 45.73 18.66
Dec 35.90 32.97 41.29 20.15



Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 34.47 31.78 38.27 16.94
Feb 31.91 28.76 35.73 19.51
Mar 29.73 26.12 33.57 22.21
Apr 32.16 30.20 34.48 12.40
May 29.10 26.01 33.14 21.52
Jun 34.03 32.41 38.75 16.35
Jul 33.64 30.83 37.67 18.16
Aug 33.89 31.77 38.79 18.10
Sep 33.89 32.16 37.76 14.84
Oct 37.05 31.91 42.19 24.36
Nov 35.92 30.74 41.04 25.11
Dec 37.08 34.34 39.20 12.40

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 35.82 31.39 37.99 17.37
Feb 36.09 33.89 39.31 13.78
Mar 38.90 35.65 42.22 15.58
Apr 36.83 32.98 40.40 18.36
May 40.75 35.10 42.37 17.17
Jun 44.15 40.71 50.53 19.43
Jul 51.12 43.64 56.17 22.31
Aug 47.82 44.45 53.99 17.67
Sep 52.27 47.70 59.72 20.12
Oct 56.24 47.80 60.51 21.01
Nov 60.30 53.08 65.57 19.05
Dec 55.14 50.12 63.00 20.46

Calliditas Therapeutics information and performance

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, has focused on identifying, developing and commercializing pharmaceutical products for the treatment of orphan symptoms with an initial focus on kidney and liver diseases. The main candidate for the company’s products is Nefekon, an oral budesonide drug that is an immunosuppressive agent for the treatment of autoimmune IgA renal nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.

Calliditas Therapeutics Address

KUNGSBRON 1, C8, STOCKHOLM, SE

Market Capitalization: 499 821 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: None

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 76.95

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.533

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 26586100

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.